From 2011–16, the HEAL TB project supported Ethiopia's Federal Ministry of Health (FMOH) in Amhara and Oromia regions to improve comprehensive TB services, including finding and treating TB in children, adults, and special populations; expanding multidrug-resistant TB (MDR-TB) diagnosis and treatment; integrating TB and HIV services; improving laboratory diagnostics and reporting; and strengthening the expertise, leadership, and management of the health system.
Drug-resistant TB: Our Projects
Medicines are indispensable to improving health and saving the lives of people who need them. To be fully effective and safe, they must also be correctly prescribed and appropriately used.
From 2011 to 2018, the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program worked to ensure equitable, affordable access to safe, quality-assured medicines and related services in 46 countries throughout Africa, Asia, Europe, Latin America and the Caribbean, the Middle East, and Oceania.
The five-year TRACK Tuberculosis (TRACK-TB) activity aimed to increase detection of TB cases and improve treatment success rates to meet national targets for reducing TB, multidrug-resistant TB (MDR-TB), and TB/HIV co-infection. The project, which began in 2013, worked with the Government of Uganda to enhance the National Tuberculosis and Leprosy Programme (NTLP)’s ability to plan, monitor, and implement TB control activities.
The USAID-funded, KNCV-led Challenge TB (CTB) project operated from 2014 to 2019 in 24 countries and two regions.